Hemostasis is a complex dynamic process involving bleeding and thrombosis as two end-
points. Conventional coagulation tests which are measured in plasma examine only isolated …

Thromboelastography (TEG) was first described by Hartert in 1948, and was designed to
monitor viscoelastic clot strength in whole blood in real time. The current TEG method and …

The thromboelastograph (TEG), a measure of global haemostasis, is routinely used during
cardiac and hepatic surgery to optimize blood product selection and usage. It has recently …

Analyzing coagulability often hinges on patient surveillance using prothrombin time (PT) or
international normalized ratio (INR) and activated partial thromboplastin time (aPTT) to …

Thromboelastometry/thromboelastography provides information about clot strength and
stability. Modified procedures have improved the standardisation and increased the …

Background: Studies investigating thromboelastometry or thrombelastography analyses in a
physiological context are scattered and not easy to access. Objective: To systematically …

While the use of thromboelastometry analysis (ROTEM®) in evaluation of haemostasis is
rapidly increasing, important validity parameters of testing remain inadequately examined …

Laboratory evaluation of hemostasis has been performed using plasma for several decades.
The cell-based model of coagulation has now led to renewed interest in the global assays of …

The ROtation ThromboElastoMetry analyser (ROTEM®, Pentapharm, Munich, Germany) is
useful for studying whole blood (WB) clot formation and lysis. Reduction of haematocrit …

Thromboelastometry (ROTEM®) is an advancement of the classical thrombelastography
(TEG), first described by Hellmut Hartert in 1948. Since then, several technical …